DN

Debasis Nayak

Active Director Director DIN 10041294
DIN 10041294 First appointment Feb 2023 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2023
Shareholding value •••• Premium profile

About Debasis Nayak

Data last updated:

Debasis Nayak is a Director at Medot Healthcare Private Limited (since 2023). The company operates in Trading. Medot Healthcare Private Limited reported revenue of ₹1.3 Lakh (FY 2023).

DIN 10041294
Primary Designation Director
Industry Trading
First Appointment 01 Feb 2023
Oldest Company Age 6 yrs
Largest company Medot Healthcare Private Limited · ₹1.3 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medot Healthcare Private Limited U51909MH2020PTC338142
Director01 Feb 20232020₹1.3 Lakh (FY 2023)Active

Board colleagues of Debasis Nayak

Directorship timeline

Open interactive timeline →
Medot Healthcare Private Limited
Premium access

Shareholding and investment profile for Debasis Nayak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Debasis Nayak

Debasis Nayak currently holds 1 directorship: Medot Healthcare Private Limited (Director, since 01 Feb 2023, revenue ₹1.3 Lakh (FY 2023)).

Debasis Nayak was first appointed on 01 Feb 2023 as Director at Medot Healthcare Private Limited.

The current boards of Debasis Nayak's companies include Ashim Das (Medot Healthcare Private Limited), Muktikanta Mohanty (Medot Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available